Cell Therapy 2017

Cell Therapy 2017 Report

Cell Therapy 2017

6th International Conference and Exhibition on Cell and Gene Therapy, was organized during Mar 27-28, 2017 at Madrid, Spain. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Exploring the novel research and innovations in Cell & gene therapy Cell Therapy 2017” which included the following scientific tracks:  

Cell Therapy
Cellular Therapy Technologies
Cell Therapy of Cardiovascular Disorders
Cell Therapy for Cancer
Cell Culture & Bioprocessing:
Cell Science & Stem Cell Research:
Cell Line Development
Tissue Science & Regenerative Medicine
Gene Therapy
Viral gene therapy
Diabetis Gene Therapy
Vectors for Gene Therapy
Molecular Epigenetics
Genetics & Genomic Medicine
Gene Therapy Commercialization
Clinical trials in cell and gene therapy
Gene Therapy for rare & Common Diseases
Gene Editing Technology
Cell Therapy for Neurological Disorders
Ethical Issues in Cell & Gene Therapy
Regulatory & Safety Aspects of Cell & Gene Therapy
Clinical Trails on Cell & Gen Therapy
Markets & Future Prospects for Cell & Gene Therapy

Cell & Gene Therapy Products The Organizing Committee would like to thank the moderator Dr. José Sánchez del Río (Carlos III Madrid University, Spain) for her contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Falk  Heinrichsohn- Cellular therapy, an autologous cellular PoC approach to satisfy patient´s needs (Aristoloft Lda,Portugal)
 

Ricardo Baptista - Development of cost efficient platforms for the industrial manufacturing of pluripotent stem cell-derived products for cell therapy: Cell expansion is the starting point (Cell and Gene Therapy Catapult, UK)

Victor Nurcombe - Affinity-selection of heparan sulfate glycosaminoglycans: A promising strategy to augment stem cell therapy (IMB A*STAR Singapore)

Various sessions were chaired and co-chaired by: Falk  Heinrichsohn - Aristoloft Lda,Portugal; Tushar Patel  - Mayo Clinic , USA;

Hans Sollinger -  University of Wisconsin School of Medicine and Public Health, USA; María Jesús del Olmo Barros- Autonomous University from Madrid, Spain

ConferenceSeries LLC has taken the privilege of felicitating Cell Therapy 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Cell Therapy 2017. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Stem Cell Research & Therapy: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the " 7^th  International Conference and Exhibition on Cell and Gene Therapy " to be organized during Mar 26-27, 2018 at Berlin, Germany.

 Mark your calendars for the upcoming Conference; we are hoping to see you soon!